Oncology

Back to articles

“Best treatment” for early-stage prostate cancer not identified; adverse effects from all

KEY POINT

A review prepared for the Agency for Healthcare Research and Quality and recently published in the Annals of Internal Medicine found that insufficient data existed comparing the efficacy and/or safety of available localized prostate cancer treatments (e.g., watchful waiting, radical prostatectomy, brachytherapy, and androgen deprivation).

SOURCES

Wilt TJ et al. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 2008; [published online February 5, 2008].